Dr. Sara Lee, MD

NPI: 1891717328
Total Payments
$1,005
2022 Payments
$133.11
Companies
5
Transactions
12

Payment Breakdown by Category

Food & Beverage$914.68 (91.0%)
Education$90.25 (9.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $914.68 11 91.0%
Education $90.25 1 9.0%

Top Paying Companies

Company Total Records Latest Year
Takeda Pharmaceuticals U.S.A., Inc. $434.24 4 $0 (2019)
Celgene Corporation $212.68 2 $0 (2017)
Amgen Inc. $194.26 2 $0 (2022)
Genentech USA, Inc. $125.44 1 $0 (2019)
Pfizer Inc. $38.31 3 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2022 $133.11 4 Amgen Inc. ($94.80)
2019 $360.42 3 Takeda Pharmaceuticals U.S.A., Inc. ($234.98)
2018 $298.72 3 Takeda Pharmaceuticals U.S.A., Inc. ($199.26)
2017 $212.68 2 Celgene Corporation ($212.68)

All Payment Transactions

12 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
12/09/2022 Pfizer Inc. ELIQUIS (Drug), COMIRNATY, PAXLOVID Food and Beverage In-kind items and services $11.66 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
10/27/2022 Pfizer Inc. ELIQUIS (Drug), COMIRNATY, PAXLOVID Food and Beverage In-kind items and services $13.41 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
10/06/2022 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $94.80 General
Category: Cardiology
09/12/2022 Pfizer Inc. ELIQUIS (Drug), PAXLOVID, NURTEC ODT Food and Beverage In-kind items and services $13.24 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
11/08/2019 Takeda Pharmaceuticals U.S.A., Inc. Food and Beverage In-kind items and services $113.60 General
06/14/2019 Takeda Pharmaceuticals U.S.A., Inc. Food and Beverage In-kind items and services $121.38 General
04/04/2019 Genentech USA, Inc. TECENTRIQ (Biological) Food and Beverage In-kind items and services $125.44 General
Category: BioOncology
11/14/2018 Takeda Pharmaceuticals U.S.A., Inc. Food and Beverage In-kind items and services $109.01 General
10/30/2018 Takeda Pharmaceuticals U.S.A., Inc. VELCADE (Drug) Education In-kind items and services $90.25 General
Category: Oncology
09/17/2018 Amgen Inc. Blincyto (Biological) Food and Beverage In-kind items and services $99.46 General
Category: Oncology
09/07/2017 Celgene Corporation Revlimid (Drug) Food and Beverage In-kind items and services $131.88 General
Category: Hematology / Oncology
07/26/2017 Celgene Corporation Revlimid (Drug) Food and Beverage In-kind items and services $80.80 General
Category: Hematology / Oncology

About Dr. Sara Lee, MD

Dr. Sara Lee, MD is a Pediatrics healthcare provider based in Cleveland, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1891717328.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sara Lee, MD has received a total of $1,005 in payments from pharmaceutical and medical device companies, with $133.11 received in 2022. These payments were reported across 12 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($914.68).

Practice Information

  • Specialty Pediatrics
  • Location Cleveland, OH
  • Active Since 07/24/2006
  • Last Updated 07/06/2011
  • Taxonomy Code 208000000X
  • Entity Type Individual
  • NPI Number 1891717328

Products in Payments

  • Revlimid (Drug) $212.68
  • TECENTRIQ (Biological) $125.44
  • Blincyto (Biological) $99.46
  • Repatha (Biological) $94.80
  • VELCADE (Drug) $90.25
  • ELIQUIS (Drug) $38.31

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pediatrics Doctors in Cleveland